Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of medical devices and systems for respiratory care, acute care, surgery, and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries, focusing on improving patient care and outcomes through innovative healthcare solutions and a commitment to 'Care by Design'.
Short position
Fisher & Paykel Healthcare (ASX:FPH) has 0.05% of its shares on issue reported as short positions as of 5 Oct 2026, or about 273,054 shares. Over the past 30 days that figure has fallen 0.08 percentage points, and over 90 days it has fallen 0.12 percentage points. Its highest recorded short interest was 1.28% in June 2018. FPH is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Fisher & Paykel Healthcare (FPH) short interest history
FPH Short Interest History
- 30-day change
- -0.08pp
- 90-day change
- -0.12pp
- 1-year change
- -0.04pp
- All-time high
- 1.28% (June 2018)
- All-time low
- 0.00% (October 2011)
Is FPH heavily shorted?
Not especially: 0.05% short interest is modest by ASX standards, ranking #502 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has FPH's short interest changed recently?
Over the past 30 days Fisher & Paykel Healthcare's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.05% of shares on issue.
What is the highest FPH's short interest has been?
Since 2010, Fisher & Paykel Healthcare's short interest peaked at 1.28% in June 2018 and bottomed at 0.00% in October 2011.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2010. See our methodology.